Clinical and Economic Outcomes Associated with Medication Errors in Kidney Transplantation | Zendy

David J. Taber | Zendy; Justin Spivey | Zendy; Victoria Tsurutis | Zendy; Nicole A. Pilch | Zendy; Holly B. Meadows | Zendy; James N. Fleming | Zendy; John W. McGillicuddy | Zendy; Charles F. Bratton | Zendy; Frank A. Treiber | Zendy; Prabhakar K. Baliga | Zendy; Kenneth D. Chavin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical and Economic Outcomes Associated with Medication Errors in Kidney Transplantation

Author(s) -

David J. Taber,

Justin Spivey,

Victoria Tsurutis,

Nicole A. Pilch,

Holly B. Meadows,

James N. Fleming,

John W. McGillicuddy,

Charles F. Bratton,

Frank A. Treiber,

Prabhakar K. Baliga,

Kenneth D. Chavin

Publication year - 2014

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.09300913

Subject(s) - medicine , interquartile range , incidence (geometry) , adverse effect , kidney transplantation , post hoc analysis , prospective cohort study , transplantation , drug reaction , clinical trial , surgery , drug , physics , psychiatry , optics

Modern immunosuppressant regimens have significantly decreased acute rejection rates, but may have increased the risk of graft loss driven by adverse drug reactions (ADRs) and medication errors (MEs). The objectives of this study were to determine the incidence and risk factors for MEs and ADRs and determine the association between transplant outcomes and these events.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research